TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

Tempus AI

Summary

This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.

Eligibility

Age range: 18–99 years
Sex: All
Healthy volunteers: No

Detailed criteria

Inclusion Criteria: 1. ≥18 years of age 2. Willing to participate in the research 3. Able to provide informed consent 4. Must be diagnosed with cancer Exclusion Criteria: 1\. Not willing or able to have additional blood samples collected

Locations (32)

Alabama Oncology
Birmingham, Alabama
Amanda.Joseph@AlabamaOncology.com
PIH Health Whittier Hospital & PIH Health Physicians
Whittier, California
kristine.bradbury@pihhealth.org 562-698-0811
Eastern CT and Hematology and Oncology Associates
Norwich, Connecticut
jchamplin@echoct.com 860-886-8362
Cancer Specialists of North Florida
Jacksonville, Florida
Erin.Shepard@CSNF.us 904-538-4488
Morehouse
Atlanta, Georgia
justyn.dawson@msm.edu
Piedmont Healthcare
Atlanta, Georgia
Jeff.Whorton@piedmont.org